Eversheds Sutherland has advised the seller of BioSalma
December 16, 2025
Eversheds Sutherland has advised the seller of BioSalmaDecember 16, 2025 Eversheds Sutherland Sweden has advised the seller of BioSalma AB in connection with the divestment to Vision Healthcare. BioSalma is a Swedish health and wellness brand offering a wide portfolio of vitamins, minerals, and nutritional supplements developed with a focus on quality, purity, and scientific rigor. With a strong presence in online pharmacies and physical retail & pharma chains, BioSalma serves a broad and loyal customer base across the Nordic region. Vision Healthcare is a Belgium based digital-first omni-channel platform dedicated to self-care and health-focused brands across Europe. With a strong foundation in consumer health, the company focuses on building innovative brands and delivering high-quality, science-backed products that support everyday wellbeing. Eversheds Sutherland’s team consisted of Jens André, Therése Berg, Gustav Dahlsjö, Matilda Frykman Krans, Rebecca Hayling and Sabrina Ibrisevic. Key contacts
Latest NewsLatest Eventsdeal alerts November 06, 2026 Eversheds Sutherland advises Mercedes-Benz on European fast-charging partne... firm news November 05, 2026 Eversheds Sutherland hires partner Peter Cheng to lead Hong Kong ECM practi... firm news October 27, 2026 Eversheds Sutherland (International) announces senior leadership appointmen... firm news October 26, 2026 hybrid Europe Action Week returns this November with a dynamic mix of events designed to help you navigate what’s next. virtual November 17, 2026 2.00pm - 5.00pm (GMT) Virtual in-person November 17, 2026 08:00 – 17:30 TradeXBank AG, Gartenstrasse 24, 8002 Zürich, Switzerland in-person November 18, 2026 9.30am - 4.30pm (GMT) London, United Kingdom |